Raymond James Financial
CDNA icon

Raymond James Financial’s CareDx CDNA Stock Holding History

Raymond James Financial’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.72M Sell
156,483
-5,508
-3% -$104K ﹤0.01% 3101
2025
Q4 		$3.05M Sell
161,991
-4,792
-3% -$80.3K ﹤0.01% 2918
2025
Q3 		$2.43M Sell
166,783
-13,836
-8% -$197K ﹤0.01% 3020
2025
Q2 		$3.53M Buy
180,619
+12,742
+8% +$226K ﹤0.01% 2626
2025
Q1 		$2.98M Sell
167,877
-4,682
-3% -$101K ﹤0.01% 2692
2024
Q4 		$3.69M Buy
+172,559
New +$4.2M ﹤0.01% 2522

Other funds holding CDNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return

Raymond James Financial's CDNA Position: Q1 2026 in Review

Raymond James Financial reduced its CareDx (CDNA) stake by 3.4% in Q1 2026, selling an estimated $104K and leaving 156,483 shares worth $2.72M. The position accounts for ﹤0.01% of the portfolio, ranked #3101.

Raymond James Financial first reported a position in CDNA in Q4 2024 and has held it in 6 quarters since. The position peaked at $3.69M in Q4 2024. 190 funds tracked by Wall St. Rank hold CDNA as of Q1 2026.

  • Raymond James Financial held 156,483 shares of CareDx worth $2.72M as of Q1 2026.
  • Raymond James Financial sold 5,508 CareDx shares in Q1 2026, an estimated $104K.
  • CareDx made up ﹤0.01% of Raymond James Financial's portfolio in Q1 2026, its #3101 holding.
  • Raymond James Financial first reported a position in CareDx in Q4 2024 and has held it in 6 quarters since.
  • Raymond James Financial's CareDx position peaked at $3.69M in Q4 2024.
  • 190 funds tracked by Wall St. Rank held CareDx as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.